These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 17582070)

  • 1. Natural history of multiple sclerosis with childhood onset.
    Renoux C; Vukusic S; Mikaeloff Y; Edan G; Clanet M; Dubois B; Debouverie M; Brochet B; Lebrun-Frenay C; Pelletier J; Moreau T; Lubetzki C; Vermersch P; Roullet E; Magy L; Tardieu M; Suissa S; Confavreux C;
    N Engl J Med; 2007 Jun; 356(25):2603-13. PubMed ID: 17582070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relapses and progression of disability in multiple sclerosis.
    Confavreux C; Vukusic S; Moreau T; Adeleine P
    N Engl J Med; 2000 Nov; 343(20):1430-8. PubMed ID: 11078767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age at disability milestones in multiple sclerosis.
    Confavreux C; Vukusic S
    Brain; 2006 Mar; 129(Pt 3):595-605. PubMed ID: 16415309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural history of multiple sclerosis: a unifying concept.
    Confavreux C; Vukusic S
    Brain; 2006 Mar; 129(Pt 3):606-16. PubMed ID: 16415308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The natural history of multiple sclerosis with childhood onset.
    Renoux C; Vukusic S; Confavreux C
    Clin Neurol Neurosurg; 2008 Nov; 110(9):897-904. PubMed ID: 18534742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the natural history and prognostic features of early onset and adult onset multiple sclerosis in Jordanian population.
    El-Salem K; Khader Y
    Clin Neurol Neurosurg; 2007 Jan; 109(1):32-7. PubMed ID: 16870328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural history of primary progressive multiple sclerosis.
    Koch M; Kingwell E; Rieckmann P; Tremlett H
    Neurology; 2009 Dec; 73(23):1996-2002. PubMed ID: 19996074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of secondary-progressive multiple sclerosis.
    Tremlett H; Yinshan Zhao ; Devonshire V
    Mult Scler; 2008 Apr; 14(3):314-24. PubMed ID: 18208898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up of neuromyelitis optica with a pediatric onset.
    Collongues N; Marignier R; Zéphir H; Papeix C; Fontaine B; Blanc F; Rodriguez D; Fleury M; Vukusic S; Pelletier J; Audoin B; Thouvenot E; Camu W; Barroso B; Ruet A; Brochet B; Vermersch P; Confavreux C; de Seze J
    Neurology; 2010 Sep; 75(12):1084-8. PubMed ID: 20855851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A representative cohort of patients with non-progressive multiple sclerosis at the age of normal life expectancy.
    Skoog B; Runmarker B; Winblad S; Ekholm S; Andersen O
    Brain; 2012 Mar; 135(Pt 3):900-11. PubMed ID: 22366800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease.
    Kremenchutzky M; Rice GP; Baskerville J; Wingerchuk DM; Ebers GC
    Brain; 2006 Mar; 129(Pt 3):584-94. PubMed ID: 16401620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benign multiple sclerosis in Crete.
    Mastorodemos V; Nikolakaki H; Tzagournissakis M; Kotzamani D; Panou T; Spanaki C; Klados G; Maris T; Kontolaimaki E; Psaroudaki K; Chlouverakis G; Georgakakis G; Plaitakis A
    Mult Scler; 2010 Jun; 16(6):701-6. PubMed ID: 20237192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is late-onset multiple sclerosis associated with a worse outcome?
    Tremlett H; Devonshire V
    Neurology; 2006 Sep; 67(6):954-9. PubMed ID: 17000960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The natural history of multiple sclerosis].
    Confavreux C; Vukusic S
    Rev Prat; 2006 Jun; 56(12):1313-20. PubMed ID: 16948219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Young-onset multiple sclerosis].
    Silva A; Sá MJ
    Rev Neurol; 1999 Jun 1-15; 28(11):1036-40. PubMed ID: 10390767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing of birth and disease progression in multiple sclerosis.
    Koch M; De Keyser J; Tremlett H
    Mult Scler; 2008 Jul; 14(6):793-8. PubMed ID: 18573829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis.
    Kappos L; Radue EW; O'Connor P; Polman C; Hohlfeld R; Calabresi P; Selmaj K; Agoropoulou C; Leyk M; Zhang-Auberson L; Burtin P;
    N Engl J Med; 2010 Feb; 362(5):387-401. PubMed ID: 20089952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with the risk of secondary progression in multiple sclerosis.
    Koch M; Uyttenboogaart M; van Harten A; De Keyser J
    Mult Scler; 2008 Jul; 14(6):799-803. PubMed ID: 18573840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disability progression in multiple sclerosis is slower than previously reported.
    Tremlett H; Paty D; Devonshire V
    Neurology; 2006 Jan; 66(2):172-7. PubMed ID: 16434648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors for early severity in a childhood multiple sclerosis cohort.
    Mikaeloff Y; Caridade G; Assi S; Suissa S; Tardieu M
    Pediatrics; 2006 Sep; 118(3):1133-9. PubMed ID: 16951008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.